Uploads Contact
/
Login Upload

  • Search Results for 'Asco 2019 Nsclc Parp Amp Chemotherapy'

ASCO 2019 NSCLC - PARP & Chemotherapy
ASCO 2019 NSCLC - PARP & Chemotherapy
mitsue-stanley
Using Non-targeted Therapies in Targeted Lung Cancer Popula
Using Non-targeted Therapies in Targeted Lung Cancer Popula
ellena-manuel
Cancer Chemotherapy Part I: General Cancer Chemotherapy
Cancer Chemotherapy Part I: General Cancer Chemotherapy
ellena-manuel
James Yang,
James Yang,
pasty-toler
Thierry
Thierry
cheryl-pisano
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
debby-jeon
Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian
Randomized Comparison of Adjuvant Aromatase Inhibitor <br />Exemestane plus Ovarian
tatiana-dople
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
luanne-stotts
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
tatiana-dople
Updates in Ovarian Cancer Care
Updates in Ovarian Cancer Care
ellena-manuel
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
ellena-manuel
PARP Inhibitors and Cancer: What Do You Need to Know?
PARP Inhibitors and Cancer: What Do You Need to Know?
pasty-toler
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
conchita-marotz
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP inhibitor,
marina-yarberry
The Use of PARP Inhibitors in Breast Cancer: Challenges
The Use of PARP Inhibitors in Breast Cancer: Challenges
calandra-battersby
Raising the Bar in the Management of Advanced/Metastatic NSCLC
Raising the Bar in the Management of Advanced/Metastatic NSCLC
debby-jeon
Antiangiogenic Agents in Advanced NSCLC
Antiangiogenic Agents in Advanced NSCLC
ellena-manuel
DISCOVER THE AWESOME POWER OF THE ASCO LOW VOLTAGE 7000 SERIES GENERA
DISCOVER THE AWESOME POWER OF THE ASCO LOW VOLTAGE 7000 SERIES GENERA
conchita-marotz
Growth Patterns and Pathobiology of Experimental and
Growth Patterns and Pathobiology of Experimental and
pamella-moone
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
stefany-barnette
EGFR-Mutated Advanced NSCLC
EGFR-Mutated Advanced NSCLC
sherrill-nordquist
Advances in the Immunotherapy of Solid Tumors
Advances in the Immunotherapy of Solid Tumors
myesha-ticknor
Pioneering the Future: Innovations and Strategies for Preventing Chemotherapy-Induced
Pioneering the Future: Innovations and Strategies for Preventing Chemotherapy-Induced
celsa-spraggs
Updates in the Treatment of Breast cancer
Updates in the Treatment of Breast cancer
alexa-scheidler